Keros Therapeutics - Stock Price History | KROS

Historical daily share price chart and data for Keros Therapeutics since 2021 adjusted for splits. The latest closing stock price for Keros Therapeutics as of September 27, 2021 is 43.71.
  • The all-time high Keros Therapeutics stock closing price was 82.74 on December 17, 2020.
  • The Keros Therapeutics 52-week high stock price is 88.80, which is 103.2% above the current share price.
  • The Keros Therapeutics 52-week low stock price is 28.50, which is 34.8% below the current share price.
  • The average Keros Therapeutics stock price for the last 52 weeks is 54.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Keros Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 44.9369 20.0800 82.7400 20.0800 70.5400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.020B $0.010B
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel treatments for hematological and musculoskeletal disorders. The company's product pipeline consists of KER-050, KER-047and KER-012 which are in clinical stage. Keros Therapeutics, Inc. is based in LEXINGTON, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29